blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2581091

EP2581091 - Use of inhaled nitrous oxide for preventing neuropathic pain induced by platinum salts [Right-click to bookmark this link]
Former [2013/16]Use of inhaled nitrous oxide or xenon for preventing neuropathic pain induced by cancer chemotherapy
[2014/21]
StatusNo opposition filed within time limit
Status updated on  07.08.2015
Database last updated on 29.07.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
L'Air Liquide Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude
75, Quai d'Orsay
75007 Paris / FR
[N/P]
Former [2013/16]For all designated states
L'Air Liquide Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude
75, Quai d'Orsay
75007 Paris / FR
Inventor(s)01 / Bessière, Baptiste
12, rue Diderot - Appartement 31
92130 Issy Les Moulineaux / FR
02 / Pype, Jan
Geraardsbergsesteenweg 48
1540 Herne / BE
03 / Simonnet, Guy
Résidence Grand Lebrun
149, Rue de l'Ecole Normale
33200 Bordeaux / FR
 [2014/22]
Former [2013/16]01 / Bessière, Baptiste
12, rue Diderot - Appartement 31
92130 Issy Les Moulineaux / FR
02 / Pype, Jan
Geraardsbergsesteenweg 48
1540 HERNE / BE
03 / Simonnet, M. Guy
Résidence Grand Lebrun
149, Rue de l'Ecole Normale
33200 BORDEAUX / FR
Representative(s)Pittis, Olivier
L'Air Liquide, S.A.
Direction de la Propriété Intellectuelle
75, Quai d'Orsay
75321 Paris Cedex 07 / FR
[2014/40]
Former [2013/16]Pittis, Olivier
L'Air Liquide, S.A., Direction de la Propriété Intellectuelle, 75, Quai d'Orsay
75321 Paris Cedex 07 / FR
Application number, filing date12179606.408.08.2012
[2013/16]
Priority number, dateFR2011005929614.10.2011         Original published format: FR 1159296
[2013/16]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP2581091
Date:17.04.2013
Language:FR
[2013/16]
Type: B1 Patent specification 
No.:EP2581091
Date:01.10.2014
Language:FR
[2014/40]
Search report(s)(Supplementary) European search report - dispatched on:EP27.11.2012
ClassificationIPC:A61K33/00, A61P23/00, A61K33/24, A61K45/06
[2014/21]
CPC:
A61K33/00 (EP,US); A61K31/555 (EP,US); A61K33/243 (EP,US);
A61K45/06 (EP,US); A61P23/00 (EP); A61P25/02 (EP);
A61P25/04 (EP); A61P29/00 (EP); A61P29/02 (EP);
A61P35/00 (EP); A61P39/00 (EP) (-)
C-Set:
A61K31/555, A61K2300/00 (US,EP);
A61K33/00, A61K2300/00 (EP,US);
A61K33/24, A61K2300/00 (US,EP)
Former IPC [2013/16]A61K33/00, A61P23/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/16]
TitleGerman:Einsatz von inhaliertem Distickstoffmonoxid (Lachgas) zur Vorbeugung gegen neuropathische Schmerzen, die durch Platinsalzen verursacht werden[2014/21]
English:Use of inhaled nitrous oxide for preventing neuropathic pain induced by platinum salts[2014/21]
French:Utilisation de protoxyde d'azote inhalé pour prévenir des douleurs neuropathiques induites par les sels de platine[2014/21]
Former [2013/16]Einsatz von inhaliertem Distickstoffmonoxid (Lachgas) oder Xenon zur Vorbeugung gegen neuropathische Schmerzen, die durch eine Chemotherapie gegen Krebserkrankungen verursacht werden
Former [2013/16]Use of inhaled nitrous oxide or xenon for preventing neuropathic pain induced by cancer chemotherapy
Former [2013/16]Utilisation de protoxyde d'azote ou de xénon inhalé pour prévenir des douleurs neuropathiques induites par une chimiothérapie anticancéreuse
Examination procedure23.04.2013Amendment by applicant (claims and/or description)
17.10.2013Examination requested  [2013/48]
02.05.2014Communication of intention to grant the patent
20.08.2014Fee for grant paid
20.08.2014Fee for publishing/printing paid
20.08.2014Receipt of the translation of the claim(s)
Divisional application(s)EP13165106.9  / EP2626075
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.05.2014
Opposition(s)02.07.2015No opposition filed within time limit [2015/37]
Fees paidRenewal fee
25.08.2014Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.08.2012
AL01.10.2014
BG01.10.2014
CY01.10.2014
CZ01.10.2014
EE01.10.2014
FI01.10.2014
HR01.10.2014
LT01.10.2014
LV01.10.2014
MC01.10.2014
MK01.10.2014
MT01.10.2014
NL01.10.2014
RS01.10.2014
SI01.10.2014
SK01.10.2014
SM01.10.2014
TR01.10.2014
NO01.01.2015
GR02.01.2015
IS01.02.2015
[2018/46]
Former [2018/31]HU08.08.2012
BG01.10.2014
CY01.10.2014
CZ01.10.2014
EE01.10.2014
FI01.10.2014
HR01.10.2014
LT01.10.2014
LV01.10.2014
MC01.10.2014
MK01.10.2014
MT01.10.2014
NL01.10.2014
RS01.10.2014
SI01.10.2014
SK01.10.2014
SM01.10.2014
TR01.10.2014
NO01.01.2015
GR02.01.2015
IS01.02.2015
Former [2017/38]HU08.08.2012
BG01.10.2014
CY01.10.2014
CZ01.10.2014
EE01.10.2014
FI01.10.2014
HR01.10.2014
LT01.10.2014
LV01.10.2014
MC01.10.2014
MT01.10.2014
NL01.10.2014
RS01.10.2014
SI01.10.2014
SK01.10.2014
SM01.10.2014
TR01.10.2014
NO01.01.2015
GR02.01.2015
IS01.02.2015
Former [2017/22]CY01.10.2014
CZ01.10.2014
EE01.10.2014
FI01.10.2014
HR01.10.2014
LT01.10.2014
LV01.10.2014
MC01.10.2014
MT01.10.2014
NL01.10.2014
RS01.10.2014
SI01.10.2014
SK01.10.2014
NO01.01.2015
GR02.01.2015
IS01.02.2015
Former [2016/18]CY01.10.2014
CZ01.10.2014
EE01.10.2014
FI01.10.2014
HR01.10.2014
LT01.10.2014
LV01.10.2014
MC01.10.2014
NL01.10.2014
RS01.10.2014
SI01.10.2014
SK01.10.2014
NO01.01.2015
GR02.01.2015
IS01.02.2015
Former [2016/12]CY01.10.2014
CZ01.10.2014
EE01.10.2014
FI01.10.2014
HR01.10.2014
LT01.10.2014
LV01.10.2014
NL01.10.2014
RS01.10.2014
SI01.10.2014
SK01.10.2014
NO01.01.2015
GR02.01.2015
IS01.02.2015
Former [2015/37]CY01.10.2014
CZ01.10.2014
EE01.10.2014
FI01.10.2014
HR01.10.2014
LT01.10.2014
LV01.10.2014
NL01.10.2014
RS01.10.2014
SK01.10.2014
NO01.01.2015
GR02.01.2015
IS01.02.2015
Former [2015/35]CY01.10.2014
CZ01.10.2014
EE01.10.2014
FI01.10.2014
HR01.10.2014
LT01.10.2014
LV01.10.2014
NL01.10.2014
RS01.10.2014
NO01.01.2015
GR02.01.2015
IS01.02.2015
Former [2015/26]CY01.10.2014
CZ01.10.2014
FI01.10.2014
HR01.10.2014
LT01.10.2014
LV01.10.2014
NL01.10.2014
RS01.10.2014
NO01.01.2015
GR02.01.2015
IS01.02.2015
Former [2015/24]CZ01.10.2014
FI01.10.2014
HR01.10.2014
LT01.10.2014
LV01.10.2014
NL01.10.2014
RS01.10.2014
NO01.01.2015
GR02.01.2015
IS01.02.2015
Former [2015/23]CZ01.10.2014
FI01.10.2014
LT01.10.2014
NL01.10.2014
NO01.01.2015
IS01.02.2015
Former [2015/21]LT01.10.2014
NL01.10.2014
NO01.01.2015
Former [2015/20]LT01.10.2014
NL01.10.2014
Former [2015/16]NL01.10.2014
Documents cited:Search[X]FR2944969  (AIR LIQUIDE [FR]) [X] 1,6-11 * page 1, paragraph 1 * * page 4, line 36 - page 5, line 5 * * claims 1,5 * * page 2, line 20 - page 3, line 6 * * page 3, line 22 - line 33 *;
 [Y]  - MERCADANTE S ET AL, "Breakthrough pain in cancer patients: Pathophysiology and treatment", CANCER TREATMENT REVIEWS 199812 GB, (199812), vol. 24, no. 6, ISSN 0305-7372, pages 425 - 432, XP008151643 [Y] 1-14 * page 429, column 1, paragraph 4 *

DOI:   http://dx.doi.org/10.1016/S0305-7372(98)90005-6
 [Y]  - BINHAS ET AL, "Douleurs cancereuses par exces de nociception chez l'adulte: mise au point sur les recommandations concernant les traitements antalgiques medicamenteux", ANNALES FRANCAISES D'ANESTHESIE ET DE REANIMATION, MASSON, PARIS, FR, (20070601), vol. 26, no. 6, doi:10.1016/J.ANNFAR.2007.03.029, ISSN 0750-7658, pages 502 - 515, XP022121490 [Y] 1-14 * page 513, column 2, paragraph 2 - page 514, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/j.annfar.2007.03.029
 [Y]  - WIJAYASIRI L ET AL, "Hereditary neuropathy with liability to pressure palsies and anaesthesia: Peri-operative nerve injury", ANAESTHESIA 200610 GB LNKD- DOI:10.1111/J.1365-2044.2006.04786.X, (200610), vol. 61, no. 10, ISSN 0003-2409, pages 1004 - 1006, XP008151637 [Y] 1-14 * page 1004, column 1, paragraph 2 - column 2, paragraph 1 * * page 1005, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1111/j.1365-2044.2006.04786.x
 [Y]  - HAGEN N A ET AL, "Assessment and management of breakthrough pain in cancer patients: Current approaches and emerging research", CURRENT PAIN AND HEADACHE REPORTS 2008 GB LNKD- DOI:10.1007/S11916-008-0042-1, (2008), vol. 12, no. 4, ISSN 1531-3433, pages 241 - 248, XP008151655 [Y] 1-14 * page 245; table 2 *

DOI:   http://dx.doi.org/10.1007/s11916-008-0042-1
 [Y]  - WEIMANN J, "Toxicity of nitrous oxide", BEST PRACTICE AND RESEARCH IN CLINICAL ANAESTHESIOLOGY 200303 GB LNKD- DOI:10.1053/BEAN.2002.0264, (200303), vol. 17, no. 1, ISSN 1521-6896, pages 47 - 61, XP008151639 [Y] 1-14 * page 54, paragraph 6 *

DOI:   http://dx.doi.org/IO.I053jbean.2003.0264
by applicantFR2944969
    - C. SIOKA ET AL., "Central and peripheral nervous system toxicity of common chemotherapeutic agents", CANCER CHEMOTHER. PHARMACOL., (2009), vol. 63, pages 761 - 767
    - S. COURAUD ET AL., "Hypersensibilité aux sels de platine", REVUE DE PNEUMO. CLINIQUE, (200802), vol. 64, no. 1, pages 20 - 26
    - M. STENGEL ET AL., "Oxaliplatin-induced painful neuropathy - Flicker of hope or hopeless pain?", PAIN, (2009), vol. 144, pages 225 - 226
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.